The president of Brazil announced on March 9 that his government will contribute $20.0 million over the next 20 years towards the Switzerland-headquartered International Finance Facility for Immunization (IFFIm). The South American country joins six European members of the international agency: France, Italy, Norway, Spain, Sweden and the UK. The object of the IFFIm is to raise $4.0 billion of financing for the development and delivery of vaccination programs across the developing world (Marketletter February 27).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze